WuXi Biologics: Three Manufacturing Sites Receive GMP Certification from the Turkish Medicines and Medical Devices Agency

2025-09-17 08:53:11

On September 17, WuXi Biologics announced that its Wuxi Biopharmaceutical Bulk Material Plant 1 (MFG1), Bulk Material Plant 2 (MFG2), and Finished Product Plant 5 (DP5) received GMP certification from the Turkish Medicines and Medical Devices Authority (TITCK). This marks WuXi Biologics' first GMP audit by TITCK.

WuXi Biologics

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Musk: XAI will certainly raise funds in the next few months, but not now
                            2025-09-20

                                    Nvidia (NVDA.O) fell further, dropping nearly 3%.
                            2025-09-17

                                    SoftBank and OpenAI's AI joint venture in Japan is severely delayed, with an update now expected in November.
                            2025-09-18

                                    HGTECH's 3.2T NPO products are used by leading industry customers
                            2025-09-24

                                    Alipay's two operating entities have completed the name change
                            2025-09-19